Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one ...
The best drug to fight malaria is facing increased resistance from the parasites it fights. Now there's an alternative in the ...
Promising results from a new malaria drug offer hope against emerging drug resistance in Africa. In a clinical trial, ...
A new antimalarial drug developed by Novartis is as effective as existing treatments and could help tackle rising drug ...
A new anti-malaria drug with a cure rate of over 97 per cent has been developed by scientists. The drug is the first to be ...
Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose ...
Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...
Novartis said its experimental treatment cured more than 99% of malaria cases in the trial, marking a big step toward ...
Scientists have created the first new anti- malaria drug in a quarter of a century to combat resistance to existing ...